Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
This report contains market size and forecasts of Radiopharmaceuticals in South Korea, including the following market information:
South Korea Radiopharmaceuticals Market Revenue, 2015-2020, 2021-2026, ($ millions)
South Korea Radiopharmaceuticals Market Consumption, 2015-2020, 2021-2026, (K Dose)
South Korea Radiopharmaceuticals Production Capacity, 2015-2020, 2021-2026, (K Dose)
Top Five Competitors in South Korea Radiopharmaceuticals Market 2019 (%)
The global Radiopharmaceuticals market was valued at 5929.1 million in 2019 and is projected to reach US$ 7964.2 million by 2026, at a CAGR of 7.7% during the forecast period. While the Radiopharmaceuticals market size in South Korea was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Radiopharmaceuticals manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Radiopharmaceuticals production and consumption in South Korea
Total Market by Segment:
South Korea Radiopharmaceuticals Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K Dose)
South Korea Radiopharmaceuticals Market Segment Percentages, By Type, 2019 (%)
- Diagnostic Radioisotopes
- Therapeutic Radioisotopes
South Korea Radiopharmaceuticals Market, By Application, 2015-2020, 2021-2026 ($ millions) & (K Dose)
South Korea Radiopharmaceuticals Market Segment Percentages, By Application, 2019 (%)
- Oncology
- Cardiology
- Other
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Radiopharmaceuticals Market Competitors Revenues in South Korea, by Players 2015-2020 (Estimated), ($ millions)
Total Radiopharmaceuticals Market Competitors Revenues Share in South Korea, by Players 2019 (%)
Total South Korea Radiopharmaceuticals Market Competitors Sales, by Players 2015-2020 (Estimated), (K Dose)
Total South Korea Radiopharmaceuticals Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
- Bracco Imaging
- Bayer
- Mallinckrodt
- Nordion
- Triad Isotopes
- Lantheus
- IBA Group
- GE Healthcare
- China Isotope & Radiation
- Jubilant Pharma
- Eli Lilly
- Advanced Accelerator Applications
- SIEMENS
- Dongcheng
Radiopharmaceuticals Market in South Korea - Manufacturing and Consumption, Outlook and Forecast 2020-2026
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Radiopharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 South Korea Radiopharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 COVID-19 Impact: South Korea Radiopharmaceuticals Overall Market Size
2.1 South Korea Radiopharmaceuticals Market Size: 2020 VS 2026
2.2 South Korea Radiopharmaceuticals Revenue, Prospects & Forecasts: 2015-2026
2.3 South Korea Radiopharmaceuticals Sales (Consumption): 2015-2026
3 Company Landscape
3.1 Top Radiopharmaceuticals Players in South Korea (including Foreign and Local Companies)
3.2 Top South Korea Radiopharmaceuticals Companies Ranked by Revenue
3.3 South Korea Radiopharmaceuticals Revenue by Companies (including Foreign and Local Companies)
3.4 South Korea Radiopharmaceuticals Sales by Companies (including Foreign and Local Companies)
3.5 South Korea Radiopharmaceuticals Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Radiopharmaceuticals Companies in South Korea, by Revenue in 2019
3.7 South Korea Manufacturers Radiopharmaceuticals Product Type
3.8 Tier 1, Tier 2 and Tier 3 Radiopharmaceuticals Players in South Korea
3.8.1 List of South Korea Tier 1 Radiopharmaceuticals Companies
3.8.2 List of South Korea Tier 2 and Tier 3 Radiopharmaceuticals Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - South Korea Radiopharmaceuticals Market Size Markets, 2020 & 2026
4.1.2 Diagnostic Radioisotopes
4.1.3 Therapeutic Radioisotopes
4.2 By Type - South Korea Radiopharmaceuticals Revenue & Forecasts
4.2.1 By Type - South Korea Radiopharmaceuticals Revenue, 2015-2020
4.2.2 By Type - South Korea Radiopharmaceuticals Revenue, 2021-2026
4.2.3 By Type - South Korea Radiopharmaceuticals Revenue Market Share, 2015-2026
4.3 By Type - South Korea Radiopharmaceuticals Sales & Forecasts
4.3.1 By Type - South Korea Radiopharmaceuticals Sales, 2015-2020
4.3.2 By Type - South Korea Radiopharmaceuticals Sales, 2021-2026
4.3.3 By Type - South Korea Radiopharmaceuticals Sales Market Share, 2015-2026
4.4 By Type - South Korea Radiopharmaceuticals Price (Manufacturers Selling Prices), 2015-2026
5 Sights by Application
5.1 Overview
5.1.1 By Application - South Korea Radiopharmaceuticals Market Size, 2020 & 2026
5.1.2 Oncology
5.1.3 Cardiology
5.1.4 Other
5.2 By Application - South Korea Radiopharmaceuticals Revenue & Forecasts
5.2.1 By Application - South Korea Radiopharmaceuticals Revenue, 2015-2020
5.2.2 By Application - South Korea Radiopharmaceuticals Revenue, 2021-2026
5.2.3 By Application - South Korea Radiopharmaceuticals Revenue Market Share, 2015-2026
5.3 By Application - South Korea Radiopharmaceuticals Sales & Forecasts
5.3.1 By Application - South Korea Radiopharmaceuticals Sales, 2015-2020
5.3.2 By Application - South Korea Radiopharmaceuticals Sales, 2021-2026
5.3.3 By Application - South Korea Radiopharmaceuticals Sales Market Share, 2015-2026
5.4 By Application - South Korea Radiopharmaceuticals Price (Manufacturers Selling Prices), 2015-2026
6 Manufacturers & Brands Profiles
6.1 Bracco Imaging
6.1.1 Bracco Imaging Corporate Summary
6.1.2 Bracco Imaging Business Overview
6.1.3 Bracco Imaging Radiopharmaceuticals Major Product Offerings
6.1.4 Bracco Imaging Sales and Revenue in South Korea (2015-2020)
6.1.5 Bracco Imaging Key News
6.2 Bayer
6.2.1 Bayer Corporate Summary
6.2.2 Bayer Business Overview
6.2.3 Bayer Radiopharmaceuticals Major Product Offerings
6.2.4 Bayer Sales and Revenue in South Korea (2015-2020)
6.2.5 Bayer Key News
6.3 Mallinckrodt
6.3.1 Mallinckrodt Corporate Summary
6.3.2 Mallinckrodt Business Overview
6.3.3 Mallinckrodt Radiopharmaceuticals Major Product Offerings
6.3.4 Mallinckrodt Sales and Revenue in South Korea (2015-2020)
6.3.5 Mallinckrodt Key News
6.4 Nordion
6.4.1 Nordion Corporate Summary
6.4.2 Nordion Business Overview
6.4.3 Nordion Radiopharmaceuticals Major Product Offerings
6.4.4 Nordion Sales and Revenue in South Korea (2015-2020)
6.4.5 Nordion Key News
6.5 Triad Isotopes
6.5.1 Triad Isotopes Corporate Summary
6.5.2 Triad Isotopes Business Overview
6.5.3 Triad Isotopes Radiopharmaceuticals Major Product Offerings
6.5.4 Triad Isotopes Sales and Revenue in South Korea (2015-2020)
6.5.5 Triad Isotopes Key News
6.6 Lantheus
6.6.1 Lantheus Corporate Summary
6.6.2 Lantheus Business Overview
6.6.3 Lantheus Radiopharmaceuticals Major Product Offerings
6.6.4 Lantheus Sales and Revenue in South Korea (2015-2020)
6.6.5 Lantheus Key News
6.7 IBA Group
6.6.1 IBA Group Corporate Summary
6.6.2 IBA Group Business Overview
6.6.3 IBA Group Radiopharmaceuticals Major Product Offerings
6.4.4 IBA Group Sales and Revenue in South Korea (2015-2020)
6.7.5 IBA Group Key News
6.8 GE Healthcare
6.8.1 GE Healthcare Corporate Summary
6.8.2 GE Healthcare Business Overview
6.8.3 GE Healthcare Radiopharmaceuticals Major Product Offerings
6.8.4 GE Healthcare Sales and Revenue in South Korea (2015-2020)
6.8.5 GE Healthcare Key News
6.9 China Isotope & Radiation
6.9.1 China Isotope & Radiation Corporate Summary
6.9.2 China Isotope & Radiation Business Overview
6.9.3 China Isotope & Radiation Radiopharmaceuticals Major Product Offerings
6.9.4 China Isotope & Radiation Sales and Revenue in South Korea (2015-2020)
6.9.5 China Isotope & Radiation Key News
6.10 Jubilant Pharma
6.10.1 Jubilant Pharma Corporate Summary
6.10.2 Jubilant Pharma Business Overview
6.10.3 Jubilant Pharma Radiopharmaceuticals Major Product Offerings
6.10.4 Jubilant Pharma Sales and Revenue in South Korea (2015-2020)
6.10.5 Jubilant Pharma Key News
6.11 Eli Lilly
6.11.1 Eli Lilly Corporate Summary
6.11.2 Eli Lilly Radiopharmaceuticals Business Overview
6.11.3 Eli Lilly Radiopharmaceuticals Major Product Offerings
6.11.4 Eli Lilly Sales and Revenue in South Korea (2015-2020)
6.11.5 Eli Lilly Key News
6.12 Advanced Accelerator Applications
6.12.1 Advanced Accelerator Applications Corporate Summary
6.12.2 Advanced Accelerator Applications Radiopharmaceuticals Business Overview
6.12.3 Advanced Accelerator Applications Radiopharmaceuticals Major Product Offerings
6.12.4 Advanced Accelerator Applications Sales and Revenue in South Korea (2015-2020)
6.12.5 Advanced Accelerator Applications Key News
6.13 SIEMENS
6.13.1 SIEMENS Corporate Summary
6.13.2 SIEMENS Radiopharmaceuticals Business Overview
6.13.3 SIEMENS Radiopharmaceuticals Major Product Offerings
6.13.4 SIEMENS Sales and Revenue in South Korea (2015-2020)
6.13.5 SIEMENS Key News
6.14 Dongcheng
6.14.1 Dongcheng Corporate Summary
6.14.2 Dongcheng Radiopharmaceuticals Business Overview
6.14.3 Dongcheng Radiopharmaceuticals Major Product Offerings
6.14.4 Dongcheng Sales and Revenue in South Korea (2015-2020)
6.14.5 Dongcheng Key News
6.15 Navidea
6.15.1 Navidea Corporate Summary
6.15.2 Navidea Radiopharmaceuticals Business Overview
6.15.3 Navidea Radiopharmaceuticals Major Product Offerings
6.15.4 Navidea Sales and Revenue in South Korea (2015-2020)
6.15.5 Navidea Key News
7 Radiopharmaceuticals Production Capacity, Export and Import Analysis
7.1 Radiopharmaceuticals Production Capacity and Value in South Korea, Situation Analysis and Prediction, 2015-2026
7.1.1 South Korea Radiopharmaceuticals Production Capacity, 2015-2026
7.1.2 South Korea Radiopharmaceuticals Production 2015-2026
7.1.3 South Korea Radiopharmaceuticals Production Value 2015-2026
7.2 Key Local Radiopharmaceuticals Manufacturers in South Korea
7.2.1 South Korea Key Local Radiopharmaceuticals Manufacturers Production Capacity
7.2.2 South Korea Key Local Radiopharmaceuticals Manufacturers Production
7.2.3 South Korea Key Local Radiopharmaceuticals Manufacturers Production Value
7.2.4 The Proportion of Radiopharmaceuticals Production Sold in South Korea and Sold Other Than South Korea by Manufacturers
7.3 Radiopharmaceuticals Export and Import in South Korea
7.3.1 South Korea Radiopharmaceuticals Export Market
7.3.2 South Korea Radiopharmaceuticals Source of Imports
8 COVID-19 Impact: Key Market Trends, Opportunity, Drivers and Restraints
8.1 PESTLE Analysis for South Korea Radiopharmaceuticals Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints
9 COVID-19 Impact on Radiopharmaceuticals Supply Chain Analysis
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Radiopharmaceuticals Distributors and Sales Agents in South Korea
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
List of Tables
Table 1. Key Players of Radiopharmaceuticals in South Korea
Table 2. Top Players in South Korea, Ranking by Revenue (2019)
Table 3. South Korea Radiopharmaceuticals Revenue by Companies, (US$, Mn), 2015-2020
Table 4. South Korea Radiopharmaceuticals Revenue Share by Companies, 2015-2020
Table 5. South Korea Radiopharmaceuticals Sales by Companies, (K Dose), 2015-2020
Table 6. South Korea Radiopharmaceuticals Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Radiopharmaceuticals Price (2015-2020) (USD/Dose)
Table 8. South Korea Manufacturers Radiopharmaceuticals Product Type
Table 9. List of South Korea Tier 1 Radiopharmaceuticals Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of South Korea Tier 2 and Tier 3 Radiopharmaceuticals Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Radiopharmaceuticals Revenue in South Korea (US$, Mn), 2015-2020
Table 12. By Type - Radiopharmaceuticals Revenue in South Korea (US$, Mn), 2021-2026
Table 13. By Type - Radiopharmaceuticals Sales in South Korea (K Dose), 2015-2020
Table 14. By Type - Radiopharmaceuticals Sales in South Korea (K Dose), 2021-2026
Table 15. By Application - Radiopharmaceuticals Revenue in South Korea, (US$, Mn), 2015-2020
Table 16. By Application - Radiopharmaceuticals Revenue in South Korea, (US$, Mn), 2021-2026
Table 17. By Application - Radiopharmaceuticals Sales in South Korea, (K Dose), 2015-2020
Table 18. By Application - Radiopharmaceuticals Sales in South Korea, (K Dose), 2021-2026
Table 19. Bracco Imaging Corporate Summary
Table 20. Bracco Imaging Radiopharmaceuticals Product Offerings
Table 21. Bracco Imaging Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 22. Bayer Corporate Summary
Table 23. Bayer Radiopharmaceuticals Product Offerings
Table 24. Bayer Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 25. Mallinckrodt Corporate Summary
Table 26. Mallinckrodt Radiopharmaceuticals Product Offerings
Table 27. Mallinckrodt Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 28. Nordion Corporate Summary
Table 29. Nordion Radiopharmaceuticals Product Offerings
Table 30. Nordion Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 31. Triad Isotopes Corporate Summary
Table 32. Triad Isotopes Radiopharmaceuticals Product Offerings
Table 33. Triad Isotopes Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 34. Lantheus Corporate Summary
Table 35. Lantheus Radiopharmaceuticals Product Offerings
Table 36. Lantheus Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 37. IBA Group Corporate Summary
Table 38. IBA Group Radiopharmaceuticals Product Offerings
Table 39. IBA Group Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 40. GE Healthcare Corporate Summary
Table 41. GE Healthcare Radiopharmaceuticals Product Offerings
Table 42. GE Healthcare Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 43. China Isotope & Radiation Corporate Summary
Table 44. China Isotope & Radiation Radiopharmaceuticals Product Offerings
Table 45. China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 46. Jubilant Pharma Corporate Summary
Table 47. Jubilant Pharma Radiopharmaceuticals Product Offerings
Table 48. Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 49. Eli Lilly Corporate Summary
Table 50. Eli Lilly Radiopharmaceuticals Product Offerings
Table 51. Eli Lilly Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 52. Advanced Accelerator Applications Corporate Summary
Table 53. Advanced Accelerator Applications Radiopharmaceuticals Product Offerings
Table 54. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 55. SIEMENS Corporate Summary
Table 56. SIEMENS Radiopharmaceuticals Product Offerings
Table 57. SIEMENS Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 58. Dongcheng Corporate Summary
Table 59. Dongcheng Radiopharmaceuticals Product Offerings
Table 60. Dongcheng Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 61. Navidea Corporate Summary
Table 62. Navidea Radiopharmaceuticals Product Offerings
Table 63. Navidea Radiopharmaceuticals Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 64. Radiopharmaceuticals Production Capacity (K Dose) of Local Manufacturers in South Korea, 2015-2020
Table 65. Radiopharmaceuticals Production (K Dose) of Local Manufacturers in South Korea, 2015-2020
Table 66. South Korea Radiopharmaceuticals Production Market Share of Local Manufacturers, 2015-2020
Table 67. Radiopharmaceuticals Production Value (US$, Mn) of Local Manufacturers in South Korea, 2015-2020
Table 68. South Korea Radiopharmaceuticals Production Value Market Share of Local Manufacturers, 2015-2020
Table 69. The Percentage of Radiopharmaceuticals Production Sold in South Korea and Sold Other Than South Korea by Manufacturers
Table 70. The Percentage of Radiopharmaceuticals Production Sold in South Korea and Sold Other Than South Korea by Manufacturers
Table 71. Dangeguojia Radiopharmaceuticals Sales (Consumption), Production, Export and Import, 2015-2020
Table 72. Raw Materials and Suppliers
Table 73. Radiopharmaceuticals Downstream Clients in South Korea
Table 74. Radiopharmaceuticals Distributors and Sales Agents in South Korea
List of Figures
Figure 1. Radiopharmaceuticals Segment by Type
Figure 2. Radiopharmaceuticals Segment by Application
Figure 3. Dangeguojia Radiopharmaceuticals Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Radiopharmaceuticals Market Size in South Korea, (US$, Mn) & (K Dose): 2020 VS 2026
Figure 6. South Korea Radiopharmaceuticals Revenue, 2015-2026 (US$, Mn)
Figure 7. Radiopharmaceuticals Sales in South Korea: 2015-2026 (K Dose)
Figure 8. The Top 3 and 5 Players Market Share by Radiopharmaceuticals Revenue in 2019
Figure 9. By Type - South Korea Radiopharmaceuticals Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - South Korea Radiopharmaceuticals Market Share, 2015-2020
Figure 11. By Type - South Korea Radiopharmaceuticals Market Share, 2020-2026
Figure 12. By Type - South Korea Radiopharmaceuticals Price (USD/Dose), 2015-2026
Figure 13. By Application - Radiopharmaceuticals Revenue in South Korea (US$, Mn), 2020 & 2026
Figure 14. By Application - South Korea Radiopharmaceuticals Market Share, 2015-2020
Figure 15. By Application - South Korea Radiopharmaceuticals Market Share, 2020-2026
Figure 16. By Application -South Korea Radiopharmaceuticals Price (USD/Dose), 2015-2026
Figure 17. South Korea Radiopharmaceuticals Production Capacity (K Dose), 2015-2026
Figure 18. South Korea Radiopharmaceuticals Actual Output (K Dose), 2015-2026
Figure 19. South Korea Radiopharmaceuticals Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of South Korea Radiopharmaceuticals Export Destination, 2019
Figure 21. The Source of Imports of South Korea Radiopharmaceuticals, 2019
Figure 22. PEST Analysis for South Korea Radiopharmaceuticals Market in 2020
Figure 23. Radiopharmaceuticals Market Opportunities & Trends in South Korea
Figure 24. Radiopharmaceuticals Market Drivers in South Korea
Figure 25. Radiopharmaceuticals Market Restraints in South Korea
Figure 26. Radiopharmaceuticals Industry Value Chain
Global Radiopharmaceutical Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 125
According to our LPI (LP Information) latest study, the global Radiopharmaceutical market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceutical is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period.
The research report highlights the growth potential of the global Radiopharmaceutical market. Radiopharmaceutical are expected to show stable growth in the future market. However, produ......
Global Radiopharmaceuticals Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 138
According to our LPI (LP Information) latest study, the global Radiopharmaceuticals market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceuticals is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period.
The research report highlights the growth potential of the global Radiopharmaceuticals market. Radiopharmaceuticals are expected to show stable growth in the future market. However, p......
Global Radiopharmaceutical Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 137
According to our (Global Info Research) latest study, the global Radiopharmaceutical market size was valued at USD 6956.7 million in 2023 and is forecast to a readjusted size of USD 11660 million by 2030 with a CAGR of 7.7% during review period.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule con......
Global Radiation Dose Management Market Research Report 2023
Published: 28-Dec-2023 Price: US 2900 Onwards Pages: 88
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Radiation Dose Management market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Landauer
- Sectra AB
- Afga-Gevaert
- INFINITT Healthcare
- Bayer Healthcare
- PACSHealth
- Koninklijke Philips
- GE Healthcar......
Global Radiation Dose Management Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 21-Dec-2023 Price: US 3380 Onwards Pages: 111
Market Overview of Global Radiation Dose Management market:
According to our latest research, the global Radiation Dose Management market looks promising in the next 5 years. As of 2022, the global Radiation Dose Management market was estimated at USD 484.67 million, and it's anticipated to reach USD 1069.95 million in 2028, with a CAGR of 14.11% during the forecast years.
The radiation dose management channel includes information of radiation dose recording software, real-ti......
Global Radiation Dose Management Market Research Report 2024 (Status and Outlook)
Published: 15-Dec-2023 Price: US 3200 Onwards Pages: 124
Report Overview:
The Global Radiation Dose Management Market Size was estimated at USD 862.70 million in 2022 and is projected to reach USD 3695.44 million by 2029, exhibiting a CAGR of 23.10% during the forecast period.
This report provides a deep insight into the global Radiation Dose Management market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche marke......
Global Radiopharmaceutical Professional Survey Report 2023, Forecast to 2028
Published: 21-Nov-2023 Price: US 3280 Onwards Pages: 133
Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adv......
Global Radiopharmaceutical Market Research Report 2023, Forecast to 2028
Published: 21-Nov-2023 Price: US 2680 Onwards Pages: 166
Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adv......
Global Radiopharmaceutical Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 14-Nov-2023 Price: US 3380 Onwards Pages: 116
Market Overview of Global Radiopharmaceutical market:
According to our latest research, the global Radiopharmaceutical market looks promising in the next 5 years. As of 2022, the global Radiopharmaceutical market was estimated at USD 7319.21 million, and it's anticipated to reach USD 13640.5 million in 2028, with a CAGR of 10.93% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global R......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
